7 | Histamine (Histamine Dihydrochloride)FDA Link
10/2012
-
11/2008 |
4 | Adenosine Triphosphate (ATP)IBA
06/2004
-
10/2002 |
3 | CarrageenanIBA
10/2010
-
11/2008 |
3 | Dopamine (Intropin)FDA LinkGeneric
12/2006
-
12/2004 |
3 | Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
08/2006
-
09/2005 |
2 | Histamine H3 Receptors (Histamine H3 Receptor)IBA
02/2011
-
10/2010 |
2 | 6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
01/2011
-
10/2010 |
2 | Analgesics (Analgesic Drugs)IBA
03/2010
-
02/2008 |
2 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2008
-
09/2006 |
2 | metabotropic glutamate receptor type 1IBA
09/2006
-
11/2005 |
2 | ApomorphineFDA Link
04/2004
-
01/2004 |
2 | 9- (3- bromo- 4- fluorophenyl)- 2,3,5,6,7,9- hexahydrothieno(3,2- b)quinolin- 8(4H)- one 1,1-dioxideIBA
10/2002
-
10/2002 |
1 | Sevoflurane (Ultane)FDA LinkGeneric
10/2017 |
1 | Anesthetics (Anesthetic Agents)IBA
10/2017 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
10/2012 |
1 | A-960656IBA
06/2012 |
1 | MK-0249IBA
01/2011 |
1 | piperidineIBA
01/2011 |
1 | 2- (4'- (5- methylhexahydropyrrolo(3,4- b)pyrrol- 1- yl)biphenyl- 4- yl)- 2H- pyridazin- 3- oneIBA
01/2011 |
1 | pitolisantIBA
01/2011 |
1 | Histamine H3 AntagonistsIBA
01/2011 |
1 | Niacinamide (Nicotinamide)FDA LinkGeneric
01/2011 |
1 | 4- (3- (methylamino)- 1- phenylpropyl)- 6- (2- (pyrrolidin- 1- yl)ethoxy)naphthalen- 1- olIBA
11/2010 |
1 | Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
11/2010 |
1 | Formaldehyde (Formol)FDA Link
10/2010 |
1 | 1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
03/2010 |
1 | ZymosanIBA
03/2010 |
1 | AminesIBA
11/2008 |
1 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
10/2008 |
1 | Histamine H4 ReceptorsIBA
10/2008 |
1 | benzonitrileIBA
10/2008 |
1 | PyrimidinesIBA
10/2008 |
1 | calpain inhibitorsIBA
09/2008 |
1 | CalpainIBA
09/2008 |
1 | 9- dimethylamino- 3- (4- methylphenyl)- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | Glutamic Acid (Glutamate)FDA Link
02/2008 |
1 | 9- dimethylamino- 3- (4- ethylphenyl)- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | A-841720IBA
02/2008 |
1 | 9- dimethylamino- 3- cycloheptyl- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | benzamideIBA
12/2006 |
1 | OximesIBA
08/2006 |
1 | 2-(3',4',5',6'-tetrahydro-2'H-(2,4') bipyridinyl-1'-yl)-N-m-tolyl-acetamideIBA
09/2005 |
1 | A-317567IBA
09/2005 |
1 | N- ((4- (2- cyanophenyl)- 1- piperazinyl)methyl)- 3- methylbenzamideIBA
09/2005 |
1 | Amiloride (Midamor)FDA LinkGeneric
09/2005 |
1 | EmeticsIBA
05/2005 |
1 | Dopamine Receptors (Dopamine Receptor)IBA
05/2005 |
1 | QuinpiroleIBA
12/2004 |
1 | Dopamine Agents (Dopaminergic Agents)IBA
07/2004 |
1 | Dopamine Agonists (Dopamine Agonist)IBA
04/2004 |
1 | ABT724IBA
04/2004 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2004 |
1 | Phosphodiesterase 5 InhibitorsIBA
03/2004 |
1 | Tolterodine Tartrate (Detrol)FDA Link
01/2003 |
1 | 1,4-dihydropyridine (dihydropyridine)IBA
10/2002 |
1 | PotassiumIBA
10/2002 |
1 | Adrenergic Receptors (Adrenergic Receptor)IBA
08/2002 |
1 | Phenylpropanolamine (Dexatrim)FDA Link
08/2002 |
1 | Midodrine (Midon)FDA LinkGeneric
08/2002 |